首页
订购/客服:400-666-5481

GBT 440

    
99.80%

GBT 440

源叶(MedMol)
S83367 一键复制产品信息
1446321-46-5
C19H19N3O3
337.3725
Voxelotor
货号 规格 价格 上海 北京 珠海 武汉 购买数量
S83367-5mg
99.80%

¥360.00

9 - - -
S83367-10mg
99.80%

¥595.00

9 - - -
S83367-50mg促销
99.80%

¥1780.00 ¥1420.00

7 - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: Voxelotor (GBT 440) is a potent inhibitor of haemoglobin S (HbS) polymerization. Voxelotor has the potential for sickle cell disease (SCD) treatment
靶点: HbS polymerization;Others
体外研究: Voxelotor (GBT440) binds to the N-terminal a chain of haemoglobin (Hb), increases haemoglobin S (HbS) affinity for oxygen, delays in vitro HbS polymerization and prevents sickling of red blood cells (RBCs)
体内研究: Voxelotor (GBT440; 100-150 mg/kg; administered twice a day by oral gavage for 9-12 days) reduces ex vivo sickling and prolongs red blood cells (RBCs) half-life in a murine model of sickle cell disease (SCD). Voxelotor shows T1/2s of 11.7, 19.1±1.5, 66.0±11, 28.8±4.0 hours for mouse (70 mg/kg; i.v.), rat (1.6 mg/kg; i.v.), dog (1 mg/kg; i.v.), and momkey (1 mg/kg; i.v.), respectively. Voxelotor shows Cmaxs of 81.9, 71.2±6.0, 5.56±1.6, and 25.2±5.5 μg/mL for mouse (30 mg/kg; p.o.), rat (7.2 mg/kg; p.o.), dog (2.5 mg/kg; p.o.), and momkey (4.25 mg/kg; p.o.), respectively. Animal Model: HbSS Townes knock-in sickle mice (SS mice) Dosage: 100 and 150 mg/kg Administration: Oral administration; twice a day; for 9-12 days Result: Reduced haemolysis. Animal Model: C57BL/6J mice, Sprague-Dawley rats, Beagle dogs and Cynomolgus monkeys Dosage: 70, 1.6, 1 and 1 mg/kg for mice, rats, dogs and monkeys, respectively30, 7.2, 2.5 and 4.25 mg/kg for mice, rats, dogs and monkeys, respectively Administration: Intravenous (IV: 70, 1 6, 1 and 1 mg/kg, respectively)Oral (PO: 30, 7 2, 2 5 and 4 3 mg/kg, respectively) Result: T1/2s of 11.7, 19.1±1.5, 66.0±11, 28.8±4.0 hours for mouse (70 mg/kg; i.v.), rat (1.6 mg/kg; i.v.), dog (1 mg/kg; i.v.), and momkey (1 mg/kg; i.v.), respectively.Cmaxs of 81.9, 71.2±6.0, 5.56±1.6, and 25.2±5.5 μg/mL for mouse (30 mg/kg; p.o.), rat (7.2 mg/kg; p.o.), dog (2.5 mg/kg; p.o.), and momkey (4.25 mg/kg; p.o.), respectively.
参考文献: 1. Oksenberg D, et al. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease. Br J Haematol. 2016 Oct;175(1):141-53. 2. Metcalf B, Chuang C, Dufu K, et al. Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell Hemoglobin. ACS Med Chem Lett. 2017;8(3):321-326.
溶解性: Soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.964 ml 14.82 ml 29.641 ml
5 mM 0.593 ml 2.964 ml 5.928 ml
10 mM 0.296 ml 1.482 ml 2.964 ml
50 mM 0.059 ml 0.296 ml 0.593 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×